Home» Circulars» Virtual Buyer Seller Meet In Pharmaceuticals With Guatemala On 13th October 2022 Back
 
Virtual Buyer Seller Meet in Pharmaceuticals with Guatemala on 13th October 2022
 

 

PxlNwLtrHeaderLogo


PXL/HO/Cir-048/2022-23                                                        Date: 06.10.2022

Hyderabad

 

 

Subject:  Virtual Buyer Seller Meet in Pharmaceuticals with Guatemala on 13th October 2022

 

We are glad to inform Pharmexcil in association with the Indian embassy in Guatemalais organizing "Virtual Buyer Seller Meet in Pharmaceuticals with Guatemala" on 13th October 2022 with an objective of greater market access of Indian pharmaceutical products in Guatemala and an initiative as such provides a platform to facilitate interactions & joint collaborations with existing and emerging entities of both the nations

 

Indian pharmaceuticals exports to Guatemala were reported at USD 77.19 Mn during FY-22 wherein the market stands to be among top 10 export destinations for Indian pharmaceutical products in the Latin American region. The market recorded a growth rate of 38.36% and there lies a vast opportunity for Indian exporters for acquiring greater share in the market.

 

Program details are as below:

 

Virtual Buyer Seller Meet in Pharmaceuticals with Guatemala

Date & Day

13th October 2022 (Friday)

Time

19: 30 hrs (IST)

Registration/Attendee Linkfor BSM

https://pharmexcil.webex.com/pharmexcil/onstage/g.php?MTID=efe3467ed1635715fedd02a052326442e

 

 

The Guatemalan pharmaceutical companies participating in the proposed BSM are interested in sourcing following products:

 

·   Vaccines, disposable supplies

·   Injectable antibiotics, Bio-technological products, Dermatological products, Nutritional Supplements, Others and Medical Devices.

·   Medical Devices and Pharmaceuticals

·   Veterinary Products

·   Antibiotics, analgesics, antivirals, anti-inflammatories, muscle relaxants, dermatological, gastrointestinal, antiparasitic, respiratory, cardiometabolic, ophthalmic, vitamins and others that may complement Guatemala's basic treatment regimen. 

·   Oncology, vaccines and biosimilars

·   Pharmaceutical Products

 

Members interested in supplying the above products are requested to share their information at https://forms.gle/Ht7bmrhmQiH3aKwc7

 

Member companies are requested to join this interactive session and gain insights on latest market trends and explore available opportunities for greater market access in Guatemala.

 

 

The tentative agenda is enclosedherewith for your ready reference.

 

With regards,

 

 

Udaya Bhaskar

Director General

 

 

Encl: Agenda